spacer
home > epc > autumn 2017 > clear lines
PUBLICATIONS
European Pharmaceutical Contractor

Clear Lines

EPC: What is barcode labelling and how is it currently utilised in pharma?

Laura Johnson: Barcode labelling is central to a range of mission-critical enterprise operations, including production and distribution; supply chain traceability, management and control; and final delivery. Each organisation has its own unique set of business processes and considerations that must be accommodated.

Barcodes are especially important in the pharmaceutical space, where they are currently used to identify the batch or lot for products travelling through the supply chain. In November 2015, the FDA issued final guidance for the Drug Supply Chain Security Act (DSCSA), detailing the use of 2D barcodes for consumer safety.

How does it ensure quality?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Laura Johnson is a Life Sciences Industry Expert at Loftware with over 20 years of expertise working with both pharma and medical device manufacturers to improve processes and meet regulatory requirements, such as serialisation, UDI and secure supply chain. Her career has also focused on the application of technology to drive efficiencies in manufacturing, warehousing and distribution environments. Laura’s expertise is on leveraging core functionality within major ERP systems, such as SAP and oracle, and implementing automatic data capture technologies, including vision inspection, printing, shop floor devices, barcode and RFID data collection.
spacer
Laura Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement